← Leaderboards
Julie E Buring
Brigham And Women'S Hospital
$63,823,301
Attributed
$97,898,965
Total exposure
13
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $7.9M · FY2005–23$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$97,898,965 · 13
By mechanism
R01$60,768,244 · 7
U01$27,603,120 · 2
T32$4,519,068 · 2
UM1$4,016,231 · 1
RC1$992,302 · 1
Top collaborators
- Joann Elisabeth Manson21 shared
- I-Min Lee17 shared
- Paul M. Ridker10 shared
- Peter Michael Wayne5 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Joann Elisabeth Manson$50,755,529
- Meryl S Leboff$9,246,227
- Christine M Albert$20,759,435
- Debra A Schaumberg$6,275,999
- Meir J Stampfer$56,174,887
Others in their field
Top investigators on “Woman”
- Chanza Baytop · Westat, Inc.$271,217,917
- Lawrence Corey · Fred Hutchinson Cancer Center$252,110,127
- Wafaa M. El-Sadr · Columbia University Health Sciences$232,152,340
- Myron S Cohen · Family Health International$208,921,087
- Barbara Driver · Westat, Inc.$190,429,693
- Judith S. Currier · University Of California Los Angeles$149,317,678
Research focus
WomanFundingBaseCardiovascular DiseasesMalignant NeoplasmsFollow-UpEventBlood SpecimenQuestionnairesDoseGeneticParticipantReportingMyocardial InfarctionCohortMedical RecordsAncillary StudyRandomizedRisk FactorsStrokeAgedClinical TrialsCardiovascular Disorder RiskCancer Prevention
Grant awards (83)
Women's Health Study: Infrastructure support for cohort follow-up$629,372
U01 · FY2023 · CA · contact PI
The VITamin D and OmegA-3 TriaL (VITAL): Post-Intervention Follow-Up$850,000
R01 · FY2022 · AT
Women's Health Study: Infrastructure support for cohort follow-up$700,997
U01 · FY2022 · CA · contact PI
The VITamin D and OmegA-3 TriaL (VITAL): Post-Intervention Follow-Up$850,000
R01 · FY2021 · AT
Women's Health Study: Infrastructure support for cohort follow-up$715,304
U01 · FY2021 · CA · contact PI
Women's Health Study: Infrastructure support for cohort follow-up$643,786
U01 · FY2020 · CA · contact PI
Women's Health Study: Infrastructure support for continued cohort follow-up$446,791
U01 · FY2020 · CA · contact PI
Women's Health Study: Infrastructure support for cohort follow-up$177,584
U01 · FY2020 · CA · contact PI
The VITamin D and OmegA-3 TriaL (VITAL)$3,368,726
R01 · FY2019 · CA
Women's Health Study: Infrastructure support for cohort follow-up$715,304
U01 · FY2019 · CA · contact PI
The VITamin D and OmegA-3 TriaL (VITAL)$200,000
R01 · FY2019 · CA
Training Program in the Epidemiology of CVD$165,797
T32 · FY2019 · HL
The VITamin D and OmegA-3 TriaL (VITAL)$3,474,603
R01 · FY2018 · CA
The Women's Health Study: Infrastructure Support for Continued Cohort Follow-up$731,142
UM1 · FY2018 · CA · contact PI
Training Program in the Epidemiology of CVD$361,210
T32 · FY2018 · HL
The VITamin D and OmegA-3 TriaL (VITAL)$200,000
R01 · FY2018 · CA
The VITamin D and OmegA-3 TriaL (VITAL)$4,413,440
R01 · FY2017 · CA
The Women's Health Study: Infrastructure Support for Continued Cohort Follow-up$835,161
UM1 · FY2017 · CA · contact PI
Training Program in the Epidemiology of CVD$344,906
T32 · FY2017 · HL
The VITamin D and OmegA-3 TriaL (VITAL)$200,000
R01 · FY2017 · CA
The VITamin D and OmegA-3 TriaL (VITAL)$4,377,141
R01 · FY2016 · CA
The Women's Health Study: Infrastructure Support for Continued Cohort Follow-up$831,076
UM1 · FY2016 · CA · contact PI
Training Program in the Epidemiology of CVD$356,136
T32 · FY2016 · HL
The VITamin D and OmegA-3 TriaL (VITAL)$186,100
R01 · FY2016 · CA
The VITamin D and OmegA-3 TriaL (VITAL)$4,335,161
R01 · FY2015 · CA
The Women's Health Study: Infrastructure Support for Continued Cohort Follow-up$885,018
UM1 · FY2015 · CA · contact PI
Training Program in the Epidemiology of CVD$347,298
T32 · FY2015 · HL
The VITamin D and OmegA-3 TriaL (VITAL)$185,925
R01 · FY2015 · CA
VITamin D and omegA-3 triaL (VITAL)$1,849,394
U01 · FY2014 · CA
Women's Health Study: Continued Follow-up$1,780,348
R01 · FY2014 · CA · contact PI
The Women's Health Study: Infrastructure Support for Continued Cohort Follow-up$733,834
UM1 · FY2014 · CA · contact PI
Use and Effectiveness of a Model Integrative Care Clinic in an Academic Hospital$621,139
R01 · FY2014 · AT · contact PI
Training Program in the Epidemiology of CVD$229,680
T32 · FY2014 · HL
VITamin D and omegA-3 triaL (VITAL)$136,162
U01 · FY2014 · CA
VITamin D and omegA-3 triaL (VITAL)$3,475,391
U01 · FY2013 · CA
Women's Health Study: Continued Follow-up$1,669,985
R01 · FY2013 · CA · contact PI
Use and Effectiveness of a Model Integrative Care Clinic in an Academic Hospital$612,080
R01 · FY2013 · AT · contact PI
Training Program in the Epidemiology of CVD$298,892
T32 · FY2013 · HL
VITamin D and omegA-3 triaL (VITAL)$154,236
U01 · FY2013 · CA
VITamin D and omegA-3 triaL (VITAL)$3,391,568
U01 · FY2012 · CA
Women's Health Study: Continued Follow-up$1,813,397
R01 · FY2012 · CA · contact PI
Use and Effectiveness of a Model Integrative Care Clinic in an Academic Hospital$684,679
R01 · FY2012 · AT · contact PI
VITamin D and omegA-3 triaL (VITAL)$167,479
U01 · FY2012 · CA
Training Program in the Epidemiology of CVD$167,326
T32 · FY2012 · HL
VITamin D and omegA-3 triaL (VITAL)$4,428,648
U01 · FY2011 · CA
Women's Health Study: Continued Follow-up$1,808,081
R01 · FY2011 · CA · contact PI
Use and Effectiveness of a Model Integrative Care Clinic in an Academic Hospital$636,161
R01 · FY2011 · AT · contact PI
Training Program in the Epidemiology of CVD$294,842
T32 · FY2011 · HL
VITamin D and omegA-3 triaL (VITAL)$4,819,957
U01 · FY2010 · CA
Women's Health Study: Continued Follow-Up$926,561
R01 · FY2010 · HL · contact PI
Women's Health Study: Continued Follow-up$848,006
R01 · FY2010 · CA · contact PI
Use and Effectiveness of a Model Integrative Care Clinic in an Academic Hospital$576,272
R01 · FY2010 · AT · contact PI
The Women's Health Study: Addition of New Data to Maximize its Research Impact$492,524
RC1 · FY2010 · HL · contact PI
Training Program in the Epidemiology of CVD$274,646
T32 · FY2010 · HL
VITamin D and omegA-3 triaL (VITAL)$5,151,147
U01 · FY2009 · CA
Women's Health Study: Continued Follow-Up$918,834
R01 · FY2009 · HL · contact PI
The Women's Health Study: Addition of New Data to Maximize its Research Impact$499,778
RC1 · FY2009 · HL · contact PI
Training Program in Epidemiologic Research on Aging$1
T32 · FY2009 · AG · contact PI
Women's Health Study: Continued Follow-up$1,680,173
R01 · FY2008 · CA · contact PI
Women's Health Study: Continued Follow-Up$875,149
R01 · FY2008 · HL · contact PI
Training Program in Epidemiologic Research on Aging$202,374
T32 · FY2008 · AG · contact PI
Women's Health Study: Continued Follow-up$1,666,176
R01 · FY2007 · CA · contact PI
Women's Health Study: Continued Follow-Up$867,893
R01 · FY2007 · HL · contact PI
Training Program in Epidemiologic Research on Aging$207,108
T32 · FY2007 · AG · contact PI
Women's Health Study: Continued Follow-up$1,668,675
R01 · FY2006 · CA · contact PI
Training Program in Epidemiologic Research on Aging$214,746
T32 · FY2006 · AG · contact PI
Women's Health Study: Continued Follow-up$1,661,840
R01 · FY2005 · CA
Women's Health Study: Continued Follow-Up$888,766
R01 · FY2005 · HL
Training Program in Epidemiologic Research on Aging$228,666
T32 · FY2005 · AG
Women's Health Study: Continued Follow-up$1,614,153
R01 · FY2004 · CA
TRAINING PROGRAM IN EPIDEMIOLOGIC RESEARCH ON AGING$74,344
T32 · FY2004 · AG
Trial of Aspirin and Vitamin E in Women$2,900,671
R01 · FY2003 · CA
TRAINING PROGRAM IN EPIDEMIOLOGIC RESEARCH ON AGING$204,865
T32 · FY2003 · AG
Trial of Aspirin and Vitamin E in Women$3,344,753
R01 · FY2002 · CA
PHYSICIANS HEALTH STUDY--CONTINUED FOLLOW UP$272,458
R01 · FY2002 · CA
TRAINING PROGRAM IN EPIDEMIOLOGIC RESEARCH ON AGING$194,886
T32 · FY2002 · AG
Trial of Aspirin and Vitamin E in Women$3,596,674
R01 · FY2001 · CA
PHYSICIANS HEALTH STUDY--CONTINUED FOLLOW UP$254,127
R01 · FY2001 · CA
TRAINING PROGRAM IN EPIDEMIOLOGIC RESEARCH ON AGING$179,429
T32 · FY2001 · AG
TRIAL OF ASPIRIN AND VITAMIN E IN WOMEN$2,097,968
R01 · FY2000 · CA
TRIAL OF ASPIRIN AND VITAMIN E IN WOMEN$1,593,706
R01 · FY2000 · HL
PHYSICIANS HEALTH STUDY--CONTINUED FOLLOW UP$248,423
R01 · FY2000 · CA
TRAINING PROGRAM IN EPIDEMIOLOGIC RESEARCH ON AGING$171,916
T32 · FY2000 · AG